These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 1503485)

  • 1. [Intensive induction chemotherapy of adult acute myelogenous leukemia by continuing daunorubicin, behenoyl-cytosine arabinoside, 6-mercaptopurine and prednisolone until marrow aplasia].
    Taguchi H; Kubonishi I; Takehara N; Uemura Y; Iwahara Y; Eguchi T; Miyagi T; Sugito S; Muneishi H; Tanaka Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1309-14. PubMed ID: 1503485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length.
    Ohno R; Kato Y; Nagura E; Murase T; Okumura M; Yamada H; Ogura M; Minami S; Suzuki H; Morishima Y
    J Clin Oncol; 1986 Dec; 4(12):1740-7. PubMed ID: 3465875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer curable by chemotherapy: acute myelogenous leukemia].
    Ohno R; Tanimoto M; Morishita Y; Morishima Y; Saito H; Yokomaku S; Nagai T; Kodera Y; Minami S
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1329-34. PubMed ID: 2730046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of 58 patients with acute leukemia].
    Sasaki A; Tsukaguchi M
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1303-7. PubMed ID: 1503484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behenoyl cytosine arabinoside, aclacinomycin A, 6-mercaptopurine, and prednisolone combination therapy for acute non-lymphocytic leukaemia in adults.
    Yoshida M; Suda K; Tsuboyama A; Sasaki R; Kitagawa S; Kano Y; Muto Y; Takaku F; Sakamoto S; Miura Y
    Eur J Haematol; 1989 Jul; 43(1):1-6. PubMed ID: 2767238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized study of individualized induction therapy with or without VCR, and of maintenance of 4 or 12 courses in adult AML: JALSG-AML87. Japan Adult Leukemia Study Group (JALSG).
    Ohno R; Kobayashi T; Morishima Y; Hiraoka A; Imai K; Asoh N; Tsubaki K; Tomonaga M; Takahashi I; Kodera K
    Leukemia; 1992; 6 Suppl 2():92-5. PubMed ID: 1578954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short-term intensive consolidation chemotherapy in the treatment of acute non-lymphocytic leukemia].
    Nagata K; Hatanaka T; Ito T; Saito M; Ono Y; Kamiya O; Ohara K
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1079-81. PubMed ID: 1626944
    [No Abstract]   [Full Text] [Related]  

  • 8. [The curative treatment of adult acute nonlymphocytic leukemia].
    Uzuka Y; Saito Y
    Rinsho Ketsueki; 1989 Aug; 30(8):1163-6. PubMed ID: 2601025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of acute myelogenous leukemia: results of combination chemotherapy with cytarabine, daunorubicin and 6-mercaptopurine.
    Ko WS; Chen LM; Hwang SH; Chao TY; Wang CC; Kao WY; Lee WC; Hwang WS
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Sep; 48(3):185-9. PubMed ID: 1657335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of conventional chemotherapy and short-term intensive chemotherapy in adult acute myeloid leukemia].
    Ohshima T
    Rinsho Ketsueki; 1989 Aug; 30(8):1175-7. PubMed ID: 2601028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
    Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
    Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of refractory acute myeloblastic leukemia who achieved partial remission by high dose cytosine arabinoside].
    Okamoto S; Ogata H; Yoshida T; Oheda Y; Murase T; Toyama K
    Rinsho Ketsueki; 1984 May; 25(5):719-23. PubMed ID: 6590900
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
    Kobayashi T; Miyawaki S; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Ohmoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Matsuoka A; Tomonaga M; Ohno R
    J Clin Oncol; 1996 Jan; 14(1):204-13. PubMed ID: 8558199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.
    Ellison RR; Mick R; Cuttner J; Schiffer CA; Silver RT; Henderson ES; Woliver T; Royston I; Davey FR; Glicksman AS
    J Clin Oncol; 1991 Nov; 9(11):2002-15. PubMed ID: 1941059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daunorubicin, cytosine arabinoside, 6-mercaptopurine riboside, and prednisolone (DCMP) combination chemotherapy for acute myelogenous leukemia in adults.
    Ohno R; Hirano M; Imai K; Koie K; Kamiya T; Nishiwaki H; Ishiguro J; Uetani T; Sako F; Imamura K
    Cancer; 1975 Dec; 36(6):1945-9. PubMed ID: 1060503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction and intensive combined therapy of acute myeloid leukemia in adults].
    Kurrle E; Ehninger G; Freund M; Heil G; Hoelzer D; Link H; Mitrou PS; Ohl S; Queisser W; Schlimok G
    Onkologie; 1988 Feb; 11(1):5-9. PubMed ID: 3283626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse].
    Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y
    Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group.
    Ohno R; Kobayashi T; Tanimoto M; Hiraoka A; Imai K; Asou N; Tomonaga M; Tsubaki K; Takahashi I; Kodera Y
    Cancer; 1993 Jun; 71(12):3888-95. PubMed ID: 8508355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Short-term intensive treatment for acute myelogenous leukemia (excluding M3 subtype) in adults].
    Ino T; Yamaguchi T; Tsuzuki M; Nomura T; Miyazaki H; Maruyama F; Kojima H; Okamoto M; Matsui T; Ezaki K; Hirano M
    Rinsho Ketsueki; 1997 Mar; 38(3):209-16. PubMed ID: 9095660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.